Back to 
UBS Group AG
UBS Group AG
SMMT
Showing 0 of 6 quarters
Position history for UBS Group AG's holdings in Summit Therapeutics Inc.
No. UBS Group exited its SMMT (Summit Therapeutics) position in Q3 2020. Its Q2 2020 13F listed 126,692 shares worth $376,000. UBS Group already held SMMT in its Q1 2019 13F, the earliest on record, and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.